Wikisage, the free encyclopedia of the second generation, is digital heritage
Lorazepam: Difference between revisions
Jump to navigation
Jump to search
(→Propofol: categ) |
mNo edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 27: | Line 27: | ||
see also Trinka et al 2015 [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/pdf/40265_2015_Article_454.pdf Pharmacotherapy for Status Epilepticus] Drugs 1491-1521. | see also Trinka et al 2015 [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/pdf/40265_2015_Article_454.pdf Pharmacotherapy for Status Epilepticus] Drugs 1491-1521. | ||
[http://www.hkmj.org/system/files/hkmj166025.pdf Review and update Hong kong epilepsy guidelines on status epilepticus] | |||
{{Wikidata|Q408265}} | {{Wikidata|Q408265}} | ||
Latest revision as of 20:07, 19 May 2017
sufficient lengh of time (viewed as 30 min.period)
Status epilepticus, ILAE view as a seizure that persists for a sufficient lengh of time, maybe 5-10 (focal) minutes.
[1]
diazepam
intravenous
Other agents
lorazepam>phenytoin
midazolam
Midazolam (or lorazepam i.v.) controls effectively 63-73% early SE[2]
clonazepam
clonazepam is more lipophylic that lorazepam, but less lipophilic than diazepam (Congdon et Forsythe (1980) Epilepsia 21:97)
Levetirazetam
comparison
Propofol
recruitment problem
see also Trinka et al 2015 Pharmacotherapy for Status Epilepticus Drugs 1491-1521.
Review and update Hong kong epilepsy guidelines on status epilepticus
